These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19761972)
1. [Erythropoietin: from the receptor to erythropoiesis stimulating agents]. Rieu P Nephrol Ther; 2009 Sep; 5(5 Suppl):1-5. PubMed ID: 19761972 [No Abstract] [Full Text] [Related]
2. Erythropoietin receptors: their role beyond erythropoiesis. Rossert J; Eckardt KU Nephrol Dial Transplant; 2005 Jun; 20(6):1025-8. PubMed ID: 15840686 [No Abstract] [Full Text] [Related]
3. The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors. Brines M Blood Purif; 2010; 29(2):86-92. PubMed ID: 20093809 [TBL] [Abstract][Full Text] [Related]
4. The molecular physiology of erythropoietin and the erythropoietin receptor. Zhu Y; D'Andrea AD Curr Opin Hematol; 1994 Mar; 1(2):113-8. PubMed ID: 9371269 [TBL] [Abstract][Full Text] [Related]
5. Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients. Sinclair AM; Todd MD; Forsythe K; Knox SJ; Elliott S; Begley CG Cancer; 2007 Aug; 110(3):477-88. PubMed ID: 17582631 [TBL] [Abstract][Full Text] [Related]
6. Erythropoietin: from molecular biology to clinical use. Lacombe C Eur Cytokine Netw; 1997 Sep; 8(3):308-10. PubMed ID: 9346370 [No Abstract] [Full Text] [Related]
10. Erythropoietin: oxygen-dependent control of erythropoiesis and its failure in renal disease. Eckardt KU Nephron; 1994; 67(1):7-23. PubMed ID: 8052371 [No Abstract] [Full Text] [Related]
11. Efficacy estimation of erythropoiesis-stimulating agents using erythropoietin-deficient anemic mice. Suzuki N; Sasaki Y; Kato K; Yamazaki S; Kurasawa M; Yorozu K; Shimonaka Y; Yamamoto M Haematologica; 2016 Sep; 101(9):e356-60. PubMed ID: 27247319 [No Abstract] [Full Text] [Related]
12. [Function, molecular structure and gene expression regulation of erythropoietin]. Miyazaki H Nihon Rinsho; 1992 Aug; 50(8):1879-84. PubMed ID: 1433979 [TBL] [Abstract][Full Text] [Related]
13. The many faces of erythropoietin: from erythropoiesis to a rational neuroprotective strategy. Grasso G; Sfacteria A Expert Opin Investig Drugs; 2008 Oct; 17(10):1407-9. PubMed ID: 18808303 [No Abstract] [Full Text] [Related]
14. Erythropoietin and the nervous system. Genc S; Koroglu TF; Genc K Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production. Masuda S; Nagao M; Sasaki R Int J Hematol; 1999 Jul; 70(1):1-6. PubMed ID: 10446487 [TBL] [Abstract][Full Text] [Related]
16. Structure and function of the erythropoietin receptor in stable erythropoietin-dependent transfectants. D'Andrea AD; Koo JW Contrib Nephrol; 1991; 88():48-56; discussion 57-8. PubMed ID: 1645637 [No Abstract] [Full Text] [Related]
17. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated. Nowrousian MR; Dunst J; Vaupel P Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin: a hormone with multiple functions. Lombardero M; Kovacs K; Scheithauer BW Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975 [TBL] [Abstract][Full Text] [Related]
19. The erythropoietin receptor in normal and cancer tissues. Jelkmann W; Bohlius J; Hallek M; Sytkowski AJ Crit Rev Oncol Hematol; 2008 Jul; 67(1):39-61. PubMed ID: 18434185 [TBL] [Abstract][Full Text] [Related]